Wearable Devices for Patient Monitoring in Long QT Syndrome
NCT ID: NCT06887387
Last Updated: 2025-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
80 participants
OBSERVATIONAL
2025-04-01
2026-09-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of an Innovative Smart T-shirt Capable to Monitor ECG Signal and Related Parameters Through the Comparison With a Holter ECG and a Smartwatch
NCT05771142
Comparison of QT Interval Readings Between Smartwatch Combined With Cardiologs Artificial Intelligence and 12-lead ECG
NCT05161065
A Wearable With Photoplethysmography and 6-lead Electrocardiography for Atrial Fibrillation Detection
NCT04281927
Accuracy of Rhythm Detection by a Wearable Smart Watch for Cardiac Arrhythmias (The WATCH-RHYTHM Study)
NCT04499807
A Home Telemonitoring System for Wearable Fetal-ECG and EHG Acquisition During Pregnancy
NCT06031142
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wearable device
This is an observational study that does not impact routine clinical care for participants
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18 years or over
* Phone with iOS version 15 or Android OS 9.0 or higher
* Able and willing to provide informed consent
Exclusion Criteria
* Ventricular pacing at recruitment
* Bundle branch block or pre-excitation at baseline
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Queen Mary University of London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William J Young, MBBS, PhD
Role: PRINCIPAL_INVESTIGATOR
Queen Mary University of London and St Bartholomew's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Barts and London Hospital NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
William Young
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
173178
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.